+1.224.938.9523

HUMAN AMYLOID IMAGING CONFERENCE

January 17-19, 2018
Miami, Florida

2018 SUPPORTERS


Funding for this conference is made possible, in part by 1 R13 AG042201 from The National Institute on Aging. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

GOLD

GOLD

The Tau Consortium is an innovative medical research program that is operated under the auspices of the Rainwater Charitable Foundation. The Consortium commissions world-class basic research and drug discovery to treat and prevent Alzheimer’s, progressive supranuclear palsy (PSP), and other tauopathies. The Tau Consortium acts with urgency and with patients in mind. It ensures that its members work collaboratively and engage with partners who can accelerate their progress. Since founding the Tau Consortium in 2009, the Rainwater Charitable Foundation has committed nearly $100 million to the program. There are currently five treatments in human trials as a result of the Rainwater family’s funding. Please visit http://tauconsortium.org for more information.

 

SILVER

PAST SUPPORTERS

2017 SUPPORTERS

 

2016 SUPPORTERS

2015hai-sponsors-web

2015 SUPPORTERS

2015-201x300

2014 SUPPORTERS

2014

2013 SUPPORTERS

2013

2012 SUPPORTERS

2012

2011 SUPPORTERS

2011

2010 SUPPORTERS

2010

2009 SUPPORTERS

2009

2008 SUPPORTERS

2008

2007 SUPPORTERS

medium_ge